TCR² Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 8, 2022

https://www.globenewswire.com/news-release/2022/11/08/2550642/0/en/TCR-Therapeutics-Reports-Third-Quarter-2022-Financial-Results-and-Provides-Corporate-Update.html

CAMBRIDGE, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq:TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for cancer patients suffering from solid tumors, today announced financial results for the third quarter ended September 30, 2022 and provided a corporate update.

Read more at globenewswire.com

Related news for (TCRR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.